Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Exner

Showing results (31-40 of 106) with videos related to

Pageof 11
Sort By:
European Journal of Clinical Investigation|September 29, 2011
Plasma myeloperoxidase level and peripheral arterial diseaseHelmuth Haslacher, Thomas Perkmann, Julia Gruenewald, et al.
Biochimie|February 21, 2006
Products of the reaction of HOCl with tryptophan protect LDL from atherogenic modificationStylianos Kapiotis, Leopold Jirovetz, Marcela Hermann, et al.
Journal of the American College of Cardiology|March 19, 2004
Heme oxygenase-1 genotype and restenosis after balloon angioplasty: a novel vascular protective factorMartin Schillinger, Markus Exner, Erich Minar, et al.
Atherosclerosis|July 28, 2005
Preoperative antithrombin III activity predicts outcome after surgical repair of acute type A aortic dissectionGottfried H Sodeck, Martin Schillinger, Marek P Ehrlich, et al.
Human Pathology|February 16, 2005
Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytomaPeter R Mazal, Markus Exner, Andrea Haitel, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 22, 2009
Clinical relevance of preformed C4d-fixing and non-C4d-fixing HLA single antigen reactivity in renal allograft recipientsMarkus Wahrmann, Gregor Bartel, Markus Exner, et al.
Journal of the American Society of Nephrology : JASN|December 1, 2001
Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatchMartin Karpinski, David Rush, John Jeffery, et al.
Transplantation|April 17, 2003
When renal allografts turn DARCStephan Segerer, Georg A Böhmig, Markus Exner, et al.
Wiener Klinische Wochenschrift|January 17, 2003
A case of severe C4d-positive kidney allograft dysfunction in the absence of histomorphologic features of rejectionAntje Habicht, Heinz Regele, Markus Exner, et al.
Radiology|March 22, 2003
Acute-phase response after stent implantation in the carotid artery: association with 6-month in-stent restenosisMartin Schillinger, Markus Exner, Wolfgang Mlekusch, et al.
Pageof 11

Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
European Journal of Clinical Investigation|September 29, 2011
Plasma myeloperoxidase level and peripheral arterial diseaseHelmuth Haslacher, Thomas Perkmann, Julia Gruenewald, et al.
Biochimie|February 21, 2006
Products of the reaction of HOCl with tryptophan protect LDL from atherogenic modificationStylianos Kapiotis, Leopold Jirovetz, Marcela Hermann, et al.
Journal of the American College of Cardiology|March 19, 2004
Heme oxygenase-1 genotype and restenosis after balloon angioplasty: a novel vascular protective factorMartin Schillinger, Markus Exner, Erich Minar, et al.
Atherosclerosis|July 28, 2005
Preoperative antithrombin III activity predicts outcome after surgical repair of acute type A aortic dissectionGottfried H Sodeck, Martin Schillinger, Marek P Ehrlich, et al.
Human Pathology|February 16, 2005
Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytomaPeter R Mazal, Markus Exner, Andrea Haitel, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 22, 2009
Clinical relevance of preformed C4d-fixing and non-C4d-fixing HLA single antigen reactivity in renal allograft recipientsMarkus Wahrmann, Gregor Bartel, Markus Exner, et al.
Journal of the American Society of Nephrology : JASN|December 1, 2001
Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatchMartin Karpinski, David Rush, John Jeffery, et al.
Transplantation|April 17, 2003
When renal allografts turn DARCStephan Segerer, Georg A Böhmig, Markus Exner, et al.
Wiener Klinische Wochenschrift|January 17, 2003
A case of severe C4d-positive kidney allograft dysfunction in the absence of histomorphologic features of rejectionAntje Habicht, Heinz Regele, Markus Exner, et al.
Radiology|March 22, 2003
Acute-phase response after stent implantation in the carotid artery: association with 6-month in-stent restenosisMartin Schillinger, Markus Exner, Wolfgang Mlekusch, et al.
Pageof 11